Gender and racial differences in lipoprotein subclass distributions: the STRRIDE study

Atherosclerosis
Johanna L JohnsonWilliam E Kraus

Abstract

Recent research has focused on the potential atherogenicity of various lipoprotein subclasses and their link to coronary heart disease (CHD) risk. This investigation seeks to identify differences in lipoprotein subclass distributions among a biracial, middle-aged population, while controlling for a number of confounding risk factors. Fasting plasma samples were analyzed in 285 sedentary, mildly dyslipidemic, overweight individuals between 40 and 65 years with no known history of CHD or diabetes. Women had lower levels of small and medium LDL, medium VLDL, large VLDL, and small HDL with a much higher concentration of large HDL than men. Whites had significantly more IDL, small LDL, medium VLDL, and large VLDL with lower levels of large LDL than blacks. HDL and LDL size were larger among blacks and women; VLDL size was greater among whites and men. There was also a trend for men to have more LDL particles than women and whites to have a higher LDL particle concentration than blacks. Within this homogenous population, there were distinct differences between gender and racial groups. Blacks and women had less atherogenic profiles than whites and men, which was not evident from the standard lipid panel.

References

Oct 1, 1966·Circulation·J W GofmanR Tandy
May 1, 1982·Metabolism: Clinical and Experimental·F C BallantyneD Ballantyne
Jul 27, 1994·JAMA : the Journal of the American Medical Association·A H Slyper
Sep 18, 1996·JAMA : the Journal of the American Medical Association·M J StampferC H Hennekens
Apr 4, 1998·The American Journal of Cardiology·R M Krauss
Jan 22, 2003·European Journal of Clinical Investigation·I LemieuxJ-P Després

❮ Previous
Next ❯

Citations

Mar 11, 2010·European Journal of Applied Physiology·Gregory C HendersonGeorge A Brooks
Mar 13, 2013·Drugs·Joe M ChehadeArshag D Mooradian
Sep 10, 2008·International Journal of Obesity : Journal of the International Association for the Study of Obesity·F MagkosB Mittendorfer
Jun 22, 2007·Nature Clinical Practice. Endocrinology & Metabolism·Ian F GodslandNishi Chaturvedi
Jan 25, 2013·AIDS Research and Human Retroviruses·Matthew J NicholaouLawrence A Kingsley
Jan 29, 2013·Cardiovascular Research·Catherine J McNealRobert W Brocia
May 13, 2010·Reproductive Sciences·Faustino R Pérez-LópezHugh S Taylor
May 7, 2010·The Journal of Clinical Endocrinology and Metabolism·Faidon MagkosBettina Mittendorfer
Apr 9, 2011·The Journal of Clinical Endocrinology and Metabolism·Xuewen WangBettina Mittendorfer
Jun 25, 2010·The American Journal of Clinical Nutrition·Ebe D'AdamoSonia Caprio
Feb 24, 2016·Metabolomics : Official Journal of the Metabolomic Society·Tarja RajalahtiOlav Martin Kvalheim
Jan 15, 2013·Journal of Clinical Lipidology·H Robert SuperkoBrenda C Garrett
Feb 7, 2012·Diabetes Research and Clinical Practice·Boon How ChewMohd Adam Bujang
Jun 9, 2009·Obstetrics and Gynecology Clinics of North America·Faidon Magkos, Bettina Mittendorfer
Dec 25, 2015·Journal of Clinical Lipidology·Terry A JacobsonUNKNOWN NLA Expert Panel
May 15, 2007·Gastroenterology·Vaneeta Bamba, Daniel J Rader
Dec 13, 2007·Journal of Clinical Lipidology·Iftikhar J KulloStephen T Turner
Feb 24, 2007·The American Journal of Cardiology·M Angelyn Bethel, Robert M Califf
Feb 13, 2007·Clinical Biochemistry·Jelena VekicVesna Spasojevic-Kalimanovska
Jun 22, 2006·American Journal of Human Biology : the Official Journal of the Human Biology Council·V Saroja VorugantiAnthony G Comuzzie
Sep 14, 2012·International Journal of Nephrology·Amy Rebecca BentleyCharles N Rotimi
Apr 14, 2016·Metabolomics : Official Journal of the Metabolomic Society·Tarja RajalahtiOlav Martin Kvalheim
May 23, 2015·Cardiovascular Drugs and Therapy·Yogita RochlaniJawahar L Mehta
Sep 14, 2016·Brain, Behavior, and Immunity·Camila HirotsuMonica L Andersen
Oct 27, 2016·International Journal of Obesity : Journal of the International Association for the Study of Obesity·W S DavidsonA S Shah
Feb 9, 2017·Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme·Gina M ManyDustin S Hittel
Nov 2, 2013·Sleep·Megan E Ruiter PetrovStephen J Glasser
Feb 1, 2007·The Journal of Clinical Endocrinology and Metabolism·Faidon MagkosBettina Mittendorfer
Jun 1, 2019·Future Cardiology·Lesly-Anne SamedyKathryn M Momary

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.